Fly News Breaks for September 20, 2016
NVS
Sep 20, 2016 | 06:34 EDT
Chardan initiated Novartis with a Buy and a $95 price target.
News For NVS From the Last 2 Days
NVS
Apr 24, 2024 | 07:26 EDT
TD Cowen analyst Yaron Werber raised the firm's price target on BeiGene (BGNE) to $236 from $235 and keeps a Buy rating on the shares. The firm updated its model to reflect lower collaborative revenue given termination of Novartis (NVS) agreement for tisle in Sep 2023.